StonvexLoading…
StonvexCore line items from STEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-23 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $112.36M | $1.64M | $6.28M | $4.69M | $3.15M |
Operating Income | Not available | $33.38M | $127.78M | $96.18M | $64.00M |
Net Income | Not available | $26.97M | $102.87M | $76.72M | $51.05M |
EPS (Diluted) | $0.54 | $0.53 | $1.99 | $1.47 | $0.97 |
Total Assets | Not available | $10.89B | $10.81B | $10.63B | $10.49B |
Total Liabilities | Not available | $9.22B | $9.14B | $8.97B | $8.89B |
Cash & Equivalents | Not available | $549.57M | $419.45M | $728.45M | $578.10M |
Free Cash Flow OCF − CapEx | Not available | $16.24M | $92.61M | $80.58M | $18.10M |
Shares Outstanding | Not available | 50.91M | 50.90M | 51.23M | 51.40M |